Table 6.II.
HPV+/p16+ | HPV-/p16- | ||
---|---|---|---|
5-year overall survival (OS) | 77% | 30% | |
Local progression | Rate
Time to progression Survival after progression |
19%
14 months 13 months |
36%
8.5 months 6 months |
Distant progression (DP) | Time to DP
Multiple sites of DP |
Up to 106 months
36% |
Up to 33 months
2% |